accountthe May 22 tornado for suspending all quarterly dividends for the rest of 2011. A clinical trial of Abbott Laboratories' (NYSE: ABT) cholesterol treatment Niaspan was stopped a year and a half early for being ineffective in preventing heart attacks and...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Markets Mixed On Sluggish Economic Expansion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account